BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31115843)

  • 1. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
    Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
    Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
    Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
    Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
    Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
    Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
    Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
    BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.
    Sharp L; O'Leary E; Kinnear H; Gavin A; Drummond FJ
    Psychooncology; 2016 Mar; 25(3):282-91. PubMed ID: 26249170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
    Cary KC; Singla N; Cowan JE; Carroll PR; Cooperberg MR
    J Urol; 2014 Apr; 191(4):964-70. PubMed ID: 24184370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the impact of androgen deprivation therapy, masculine self-esteem, and psychological flexibility on distress and quality of life in men with prostate cancer.
    Chowdhury E; Horrocks T; McAteer G; Gillanders D
    Psychooncology; 2024 Jan; 33(1):e6277. PubMed ID: 38282234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
    Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
    Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in prostate cancer patients taking androgen deprivation therapy.
    Dacal K; Sereika SM; Greenspan SL
    J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
    Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
    J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Nelson AM; Gonzalez BD; Jim HS; Cessna JM; Sutton SK; Small BJ; Fishman MN; Zachariah B; Jacobsen PB
    Support Care Cancer; 2016 Oct; 24(10):4159-66. PubMed ID: 27142516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study.
    Wright P; Wilding S; Watson E; Downing A; Selby P; Hounsome L; Wagland R; Brewster DH; Huws D; Butcher H; Mottram R; Kearney T; Allen M; Gavin A; Glaser A
    Cancer Epidemiol; 2019 Jun; 60():201-207. PubMed ID: 31071525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study.
    Matheson L; Wilding S; Wagland R; Nayoan J; Rivas C; Downing A; Wright P; Brett J; Kearney T; Cross W; Glaser A; Gavin A; Watson E
    Psychooncology; 2019 Jul; 28(7):1567-1575. PubMed ID: 31132801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.